Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Phospholipase A 2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

Phospholipase A 2 activation as a therapeutic approach for cognitive enhancement in early-stage... The use of positive modulators of PLA 2 (especially of cPLA 2 and iPLA 2 ) or supplementation with dietary lipid compounds (e.g., arachidonic acid) in combination with cognitive training could be a valuable therapeutic strategy for cognitive enhancement in early-stage AD. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

Phospholipase A 2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

Loading next page...
 
/lp/springer-journals/phospholipase-a-2-activation-as-a-therapeutic-approach-for-cognitive-ph10F2UKkF

References (182)

Publisher
Springer Journals
Copyright
Copyright © 2009 by Springer-Verlag
Subject
Biomedicine; Psychiatry ; Pharmacology/Toxicology ; Neurosciences
ISSN
0033-3158
eISSN
1432-2072
DOI
10.1007/s00213-008-1351-0
pmid
18853146
Publisher site
See Article on Publisher Site

Abstract

The use of positive modulators of PLA 2 (especially of cPLA 2 and iPLA 2 ) or supplementation with dietary lipid compounds (e.g., arachidonic acid) in combination with cognitive training could be a valuable therapeutic strategy for cognitive enhancement in early-stage AD.

Journal

PsychopharmacologySpringer Journals

Published: Jan 1, 2009

There are no references for this article.